News: research and publications

Our team member Pavel attended the CSHG 2023 conference in Cyprus and presented our research there.

We are working on editing defective genes with CRISPR, a method we hope can cure all primary immunodeficiency diseases in the future. The technique we

Pavel Kopcil attended the eight annual meeting on Genome engineering: CRISPR Frontiers at Cold Spring Harbor Laboratory in New York.

We’ve won the European Genomics Grant from Standard BioTools! As the prize we will have the C1 system from Standard BioTools™ installed in our laboratory.

Aftenposten run a focused life science collection. Our laboratory was featured as representatives of NCMM in an article about new therapies for serious diseases in

Kata presented her work on CRISPR-Cas9 T cell pipeline optimisation at the American Society for Gene and Cell Therapy (ASGCT) conference in Washington D.C. The

We are very happy to announce that we’ve received a 19.9 million NOK grant from the Research Council of Norway to research personalised gene editing

We are delighted to present our newest article, “Rapid genome editing by CRISPR-Cas9-POLD3 fusion”, published in eLife in December 2021. Abstract Precision CRISPR gene editing relies on

The Norwegian Cancer Society has granted our lab NOK 7 970 000 for developing CRISPR-Cas gene therapy for blood cancer predisposition syndromes for 2022-2025. The